ZYNEZynerba Pharma CS

$4.92
$0.11 (2%)

Zynerba Pharma CS (ZYNE) Stock Analysis

Create a FREE Account to View Full ZYNE Stock Report

Zynerba Pharma CS (ZYNE) Analyst Forecast

Next 12 months ➝Current Price$4.9252-week High$16.4752-week Low$4.38MEAN$17.92+264.15%HIGH$26.00+428.46%LOW$7.50+52.44%
  • Last Price$4.92
  • Previous Close$4.81
  • Change $0.11
  • Open$4.81
  • Volume405,676
  • Avg. Volume (100-day)550,245
  • Market Capitalization$114.13M
  • Days Range $4.69 - $4.98
  • 52-week Range $4.38 - $16.47
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-1.45
  • Earnings Date03/09/2020
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta0.294
  • PEG Ratio
  • Volatility0.82
  • Average True Range0.06
Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.